Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Edoxaban (Lixiana) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.
OVERVIEW | |
---|---|
Interface: | Ovid |
Databases: | Embase 1974 to present |
MEDLINE Daily and MEDLINE 1946 to present | |
MEDLINE In-Process & Other Non-Indexed Citations | |
Note: Subject headings have been customized for each database. Duplicates between databases were removed in Ovid. | |
Date of Search: | October 7, 2016 |
Alerts: | Weekly search updates until February 15, 2016 |
Study Types: | No search filters were applied |
Limits: | No language or date limits |
Human only | |
Conference abstracts were excluded | |
SYNTAX GUIDE | |
/ | At the end of a phrase, searches the phrase as a subject heading |
.sh | At the end of a phrase, searches the phrase as a subject heading |
MeSH | Medical Subject Heading |
fs | Floating subheading |
exp | Explode a subject heading |
* | Before a word, indicates that the marked subject heading is a primary topic; or, after a word, a truncation symbol (wildcard) to retrieve plurals or varying endings |
# | Truncation symbol for one character |
? | Truncation symbol for one or no characters only |
adj | Requires words are adjacent to each other (in any order) |
adj# | Adjacency within # number of words (in any order) |
.ti | Title |
.ab | Abstract |
.ot | Original title |
.hw | Heading word; usually includes subject headings and controlled vocabulary |
.pt | Publication type |
.rn | CAS registry number |
.nm | Name of substance word |
pmez | Ovid database code; MEDLINE In-Process & Other Non-Indexed Citations, MEDLINE Daily and Ovid MEDLINE 1946 to Present |
oemezd | Ovid database code; Embase 1974 to present, updated daily |
MULTI-DATABASE STRATEGY | |
---|---|
# | Searches |
1 | (Edoxaban* or Lixiana* or Savaysa* or DU 176* or DU176* or 32W99UE810 or UNII32W99UE810 or 606P02282F or UNII606P02282F or NDU3J18APO or UNIINDU3J18APO or 972203R4EW or UNII972203R4EW).ti,ab,kf,kw,ot,hw,rn,nm. |
2 | (480448 29 1 or “480448291” or 48044829 1 or 48044829 1 or “0480448291” or 480449 70 5 or 48044970 5 or “480449705” or 480449 705 or 480449 71 6 or “480449716” or 48044971 6 or 480449 716 or 1229194 11 9 or “1229194119” or “122919411 9” or 1229194 119).rn,nm. |
3 | 1 or 2 |
4 | 3 use ppez |
5 | exp *edoxaban/ |
6 | (Edoxaban* or Lixiana* or Savaysa* or DU 176* or DU176*).ti,ab,kw. |
7 | 5 or 6 |
8 | 7 use oemezd |
9 | 4 or 8 |
10 | exp animals/ |
11 | exp animal experimentation/ or exp animal experiment/ |
12 | exp models animal/ |
13 | nonhuman/ |
14 | exp vertebrate/ or exp vertebrates/ |
15 | animal.po. |
16 | or/10–15 |
17 | exp humans/ |
18 | exp human experimentation/ or exp human experiment/ |
19 | human.po. |
20 | or/17–19 |
21 | 16 not 20 |
22 | 9 not 21 |
23 | 22 not conference abstract.pt. |
24 | remove duplicates from 23 |
OTHER DATABASES | |
---|---|
PubMed | Same MeSH, keywords, limits, and study types used as per MEDLINE search, with appropriate syntax used. |
Trial registries (Clinicaltrials.gov and others) | Same keywords, limits used as per MEDLINE search. |
Grey Literature
Dates for Search: | October 10, 2016. |
Keywords: | Drug name, Indication |
Limits: | No language or date limits used |
Relevant websites from the following sections of the CADTH grey literature checklist, “Grey matters: a practical tool for evidence-based searching” (http://www.cadth.ca/en/resources/finding-evidence-is/grey-matters) were searched:
- Health Technology Assessment Agencies
- Health Economics
- Clinical Practice Guidelines
- Drug and Device Regulatory Approvals
- Advisories and Warnings
- Drug Class Reviews
- Databases (free)
- Internet Search.
- LITERATURE SEARCH STRATEGY - Edoxaban (Lixiana)LITERATURE SEARCH STRATEGY - Edoxaban (Lixiana)
- Homo sapiens thioredoxin related transmembrane protein 2 (TMX2), transcript vari...Homo sapiens thioredoxin related transmembrane protein 2 (TMX2), transcript variant 8, mRNAgi|1890327931|ref|NM_001347893.2|Nucleotide
- REFERENCES - Omalizumab (Xolair)REFERENCES - Omalizumab (Xolair)
- INTRODUCTION - Omalizumab (Xolair)INTRODUCTION - Omalizumab (Xolair)
- CONCLUSIONS - Edoxaban (Lixiana)CONCLUSIONS - Edoxaban (Lixiana)
Your browsing activity is empty.
Activity recording is turned off.
See more...